We use cookies for site personalization, analytics and advertising. You can opt out of third party cookies. More info in our privacy policy.   Got it

Top stories about india

This article is more than seven years old.

... time for the poor and the sick. Two cases brought to India’s courts by transnational pharmaceutical companies ... Swiss drugmaker Novartis which was refused a patent in India for its anti-cancer drug Glivec (imatinib) and is now ... impact on access to medicines in countries such as India. Irekia under a CC License ‘People are already dying ...
default_thumbnail

This article is almost seven years old.

... absorbable and therefore worthy of a fresh patent. But the India courts threw out the application on the grounds the new ... not only can Glivec continue to be produced cheaper in India – at a cost of around £115 ($175) per month, rather ... a legal precedent for other drugs. Due to its patent laws, India produces the majority of generic drugs for poor ...

Subscribe   Ethical Shop